We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Preparation Methods to Measure Free Cortisol Evaluated

By LabMedica International staff writers
Posted on 04 Oct 2011
The assessment of free rather that total cortisol may be beneficial for the diagnosis of critical illness-related cortisol insufficiency.

Centrifugal ultrafiltration could provide timely free cortisol data that should correlate with the equilibrium dialysis technique when the free cortisol fractions are identically quantified by chemiluminescence immunoassay.

A prospective, multi-institutional, observational cohort investigation has been carried out involving seven pediatric intensive care units within the Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (Rockville, MD, USA). More...
Blood samples from165 critically ill children across the spectrum of illness severity were analyzed. Temperature-controlled centrifugal ultrafiltration (CUF) was conducted using YM-30 membrane fitters and compared with equilibrium dialysis, the gold standard, using the Rapid Equilibrium Dialysis Device. The cortisol assays were performed at using the VITROS ECi Immunodiagnostic System (Ortho Clinical Diagnostics, Rochester, NY, USA) using enhanced chemiluminescence detection.

The time to derive plasma free cortisol concentrations after centrifugal ultrafiltration was approximately 2 hours compared with the 24 hours after the equilibrium dialysis fractionation with chemiluminescence immunoassay. When using the CUF with a 30,000 molecular weight cutoff (Millipore, Billerica, MA, USA) the mean plasma free cortisol was 4.1 ± 6.7 µg/dL, representing an average of 15.2 ± 9.4% of total cortisol. Nearly 60% of subjects exhibited free cortisol of less than 2 μg/dL, and 30% had less than 0.8 µg/dL, which are previously suggested threshold concentrations for defining critical illness-related cortisol insufficiency. A strong correlation was demonstrated for the plasma-free cortisol concentrations when comparing CUF and the Pierce Protein Research Product's equilibrium dialysis fractionation (Thermo Fisher Scientific Inc, Rockford, IL, USA).

The authors concluded that the determination of CUF fractionated free cortisol was fast and results correlated highly with equilibrium dialysis fractionated free cortisol. Many children exhibited free cortisol of less than 2 µg/dL and 0.8 µg/dL, but did not demonstrate clinical evidence of critical illness-related cortisol insufficiency. The study ascertained that real-time free cortisol quantification, for the determination of adrenal function, is feasible to potentially help guide clinical decision making for cortisol replacement therapy in the pediatric intensive care unit. The study was published in September 2011, in Pediatric Critical Care Medicine.

Related Links:
Eunice Kennedy Shriver National Institute of Child Health
Ortho Clinical Diagnostics
Thermo Fisher Scientific



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Thyroid Test
Anti-Thyroid EIA Test
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.